青少年帕金森症与二皮里米丁酶缺乏症相关
1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pediatrics
|November 19, 2024
概括
青少年帕金森症是一种罕见的疾病,与一种新型二二胺酶 (DPYS) 基因变异有关. 利沃多巴治疗有效地改善了这种代谢障碍患者的运动症状.
科学领域:
- 遗传学 遗传学 是一个
- 代谢障碍 代谢障碍 代谢障碍
- 神经学 神经学
背景情况:
- 青少年帕金森症 (JP) 是罕见的,在21岁之前开始.
- 遗传原因越来越多地被确定,但代谢联系的定义较少.
研究的目的:
- 确定青少年帕金森症的新型遗传和代谢原因.
- 报告与二胺酶缺乏相关的JP的第一个病例.
主要方法:
- 整体外体序列测定在DPYS基因中发现了复合异合体变异体.
- 泌尿代谢组分析证实了皮里米丁代谢受损.
- 临床评估和对利沃多巴治疗的反应.
主要成果:
- 在一个13岁的JP.患者身上发现了一种新的DPYS变体.
- 升高的二甲和二甲胺证实了皮里米丁代谢障碍.
- 利沃多巴治疗显著改善了运动症状.
结论:
- DPYS缺乏症是青少年帕金森症的新型遗传原因.
- 利沃多巴治疗在DPYS相关的帕金森症中治疗运动功能障碍方面表现出有效性.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.5K
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
7.3K
相关概念视频
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Parkinson's Disease: Treatment
222
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Inborn Errors of Metabolism
131
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
131
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
